Panacea Life Sciences Holdings, Inc. Increase (Decrease) in Accounts Payable, Related Parties
Panacea Life Sciences Holdings, Inc. (PLSH) reported Increase (Decrease) in Accounts Payable, Related Parties of $0 for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-24.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties · last filed 2021-05-24
- Panacea Life Sciences Holdings, Inc. increase (decrease) in accounts payable, related parties for the quarter ending 2021-03-31 was $0.00.
- Panacea Life Sciences Holdings, Inc. increase (decrease) in accounts payable, related parties for the quarter ending 2020-12-31 was -$8.34K, a 101.87% decline year-over-year.
- Panacea Life Sciences Holdings, Inc. increase (decrease) in accounts payable, related parties for the quarter ending 2020-09-30 was -$17.50K, a 1207.59% decline year-over-year.
- Panacea Life Sciences Holdings, Inc. increase (decrease) in accounts payable, related parties for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- Panacea Life Sciences Holdings, Inc. increase (decrease) in accounts payable, related parties for fiscal 2020 was -$25.84K, a 105.69% decline from fiscal 2019.
- Panacea Life Sciences Holdings, Inc. increase (decrease) in accounts payable, related parties for fiscal 2019 was $454.51K.
- Panacea Life Sciences Holdings, Inc. increase (decrease) in accounts payable, related parties for fiscal 2018 was $0.00.
| Period end | Increase (Decrease) in Accounts Payable, Related Parties 3 month | Increase (Decrease) in Accounts Payable, Related Parties 6 month | Increase (Decrease) in Accounts Payable, Related Parties 9 month | Increase (Decrease) in Accounts Payable, Related Parties 12 month |
|---|---|---|---|---|
| 2021-03-31 | $0.00 10-Q · filed 2021-05-24 | -$8.34K derived: sum of 2 quarters · filed 2021-05-24 | -$25.84K derived: sum of 3 quarters · filed 2021-05-24 | -$25.84K derived: sum of 4 quarters · filed 2021-05-24 |
| 2020-12-31 | -$8.34K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-23 | -$25.84K derived: sum of 2 quarters · filed 2021-04-23 | -$25.84K derived: sum of 3 quarters · filed 2021-04-23 | -$25.84K 10-K/A · filed 2021-04-23 |
| 2020-09-30 | -$17.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-18 | -$17.50K derived: sum of 2 quarters · filed 2020-11-18 | -$17.50K 10-Q · filed 2020-11-18 | $428.67K derived: sum of 4 quarters · filed 2021-05-24 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-19 | $0.00 10-Q · filed 2020-08-19 | $446.17K derived: sum of 3 quarters · filed 2021-05-24 | $447.75K derived: sum of 4 quarters · filed 2021-05-24 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-24 | $446.17K derived: sum of 2 quarters · filed 2021-05-24 | $447.75K derived: sum of 3 quarters · filed 2021-05-24 | $476.07K derived: sum of 4 quarters · filed 2021-05-24 |
| 2019-12-31 | $446.17K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-23 | $447.75K derived: sum of 2 quarters · filed 2021-04-23 | $476.07K derived: sum of 3 quarters · filed 2021-04-23 | $454.51K 10-K/A · filed 2021-04-23 |
| 2019-09-30 | $1.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-18 | $29.90K derived: sum of 2 quarters · filed 2020-11-18 | $8.34K 10-Q · filed 2020-11-18 | $8.34K derived: sum of 4 quarters · filed 2020-11-18 |
| 2019-06-30 | $28.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-19 | $6.76K 10-Q · filed 2020-08-19 | $6.76K derived: sum of 3 quarters · filed 2020-08-19 | |
| 2019-03-31 | -$21.56K 10-Q · filed 2020-06-29 | -$21.56K derived: sum of 2 quarters · filed 2020-06-29 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-22 | $0.00 10-K · filed 2020-05-22 | ||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-14 |